Myelodysplastic Syndrome with Genetic Abnormalities

Myelodysplastic Syndrome with Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: University Hospital, Brest
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01141725	Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS	completed	Phase 1 / Phase 2	39	Fred Hutchinson Cancer CenterOTHER	1	Aug 18, 2017	clinicaltrials
NCT00839982	Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS	completed	Phase 1 / Phase 2	35	Fred Hutchinson Cancer CenterOTHER	1	Jul 11, 2017	clinicaltrials